8357 — Republic Healthcare Income Statement
0.000.00%
Last trade - 00:00- HK$60.53m
- -HK$2.05m
- SG$8.66m
- 56
- 25
- 60
- 45
Annual income statement for Republic Healthcare, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | — | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 13.7 | 13.4 | 9.04 | 10 | 8.66 |
| Cost of Revenue | |||||
| Gross Profit | 9.6 | 9.13 | 5.97 | 6.83 | 5.9 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 13.8 | 14.4 | 10.5 | 10.8 | 8.84 |
| Operating Profit | -0.114 | -1.02 | -1.46 | -0.828 | -0.184 |
| Net Income Before Taxes | -0.114 | -1.02 | -1.46 | -0.828 | -0.184 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.144 | -0.998 | -1.48 | -0.855 | -0.178 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.144 | -0.998 | -1.48 | -0.855 | -0.178 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.144 | -0.998 | -1.48 | -0.855 | -0.178 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.002 | -0.002 | -0.001 | -0 |